Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 USD | +4.21% | -7.86% | +2.77% |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 05 | North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited | DJ |
Financials (USD)
Sales 2024 * | 139M | Sales 2025 * | 166M | Capitalization | 405M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -4M | EV / Sales 2024 * | 2.92 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
-25
x | P/E ratio 2025 * |
-103
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Avid Bioservices, Inc.
1 day | +0.31% | ||
1 week | -5.74% | ||
Current month | -4.33% | ||
1 month | -4.75% | ||
3 months | -2.73% | ||
6 months | -4.33% | ||
Current year | -1.38% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 6.68 | +4.21% | 702 786 |
24-04-22 | 6.41 | +0.31% | 511,100 |
24-04-19 | 6.39 | -1.99% | 793,712 |
24-04-18 | 6.52 | -2.83% | 707,733 |
24-04-17 | 6.71 | -7.45% | 1,153,301 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.38% | 405M | |
-2.73% | 85.68B | |
+5.53% | 41.4B | |
-24.99% | 28.22B | |
+54.63% | 24.64B | |
-7.19% | 16.98B | |
-34.20% | 13.29B | |
-17.31% | 11.66B | |
-11.43% | 11.65B | |
-1.57% | 8.18B |
- Stock Market
- Equities
- CDMO Stock